Biocon Limited has informed the Exchange regarding a press release dated November 30, 2023, titled "Biocon Biologics Successfully Completes Integration of Viatris Biosimilar Business in 31 Countries in Europe".
Biocon Limited has informed the Exchange regarding a press release dated November 30, 2023, titled "Biocon Biologics Successfully Completes Integration of Viatris Biosimilar Business in 31 Countries in Europe".